melanocortin modulators (Novartis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemelanocortin modulators (Novartis)
Drug Alias NameMC-1, MC-3/4, MC-4 program (Trega/Novartis)cytokine regulators (Trega/Ono)melanocortin modulators (Lion/Novartis)melanocortin modulators (Trega/Ono)MC-1, MC-3/4, MC-4 program (Lion/Novartis) +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 3 modulatorsMelanocortin receptor 4 modulatorsMelanocortin receptor 1 modulators
TargetsMelanocortin receptor 1Melanocortin receptor 4Melanocortin receptor 3
Therapy Area/IndicationsImmune System DiseasesObesityDiabetes Mellitus, Type 2 +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwest Neurologic Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwest Neurologic IncLION bioscience IncNovartis Pharma Ag +[4] 
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesObesityDiabetes Mellitus, Type 2 +[4] 

Other Information

ATC CodeN/A
Related LinksN/A